MoneyLion operates a “content-as-a-service platform” called mFeed, and Stifel Discover is expected to deliver personalized ...

Stifel analysts increased their price target for Ecolab Inc . (NYSE:ECL) shares to $307.00, up from the previous $285.00, while reiterating a Buy rating on the stock. The company, currently valued at ...

Proprietary Insights – Stifel Discover delivers exclusive analysis and commentary from Stifel’s Chief Investment Officer, Chief Economist, Chief Washington Policy Strategist, equity research analysts, ...

Stifel Financial (SF) announced the launch of Stifel Discover, a new Stifel-branded content feed available through its Wealth Tracker app. The ...

Investing.com-- Stifel analysts said in a recent note that logistics and freight firms with exposure to North American trade were likely to see limited impact from President-elect Donald Trump’s ...

Shares of Stifel Financial were moving higher after it reported fourth-quarter adjusted earnings that beat Wall Street estimates thanks to a surge in investment banking revenue.

which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Stifel: unfavorable. While the ...

ST. LOUIS, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.36 billion for the three months ended December 31, 2024, compared with $1.15 ...

Twilio (NYSE:TWLO – Get Free Report) had its price objective upped by stock analysts at Stifel Nicolaus from $110. ... and sold shares of TWLO. True Wealth Design LLC grew its position in shares ...

Thursday, January 23, 2025, marks the release of a new report by Stifel analysts on the US transport sector. The report outlines a cautious perspective on the industry's future, noting that while 2024 ...

Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...

Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...